Juliana Lawrence

Juliana Lawrence

Auto-generated profile, based on publicly available information

Juliana Lawrence

Brigham and Women’s Hospital, Department of Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Otology & Neurotology
Verified
Journal Article
Closed access
ALAlexander L. Luryi
Alexander L. Luryi
JLJuliana Lawrence
Juliana Lawrence
DBDennis I. Bojrab
Dennis I. Bojrab
MLMichael LaRouere
Michael LaRouere
SBSeilesh Babu
Seilesh Babu
CSChristopher A. Schutt
Christopher A. Schutt
Objective: To report rates of recurrence in benign paroxysmal positional vertigo (BPPV) and associated patient and disease factors. Study Design: Retrospective chart review. Setting: Single high-volume otology practice. Patients: Patients diagnosed with BPPV from 2007 to 2016 with documented resolution of symptoms. Intervention: Diagnostic and particle repositioning maneuvers for BPPV. Main Outcome Measures: BPPV recurrence, time to recurrence, and ear(s) affected at recurrence. Results: A total of 1,105 patients meeting criteria were identified. Of this population, 37% had recurrence of BPPV in either ear or both ears. Overall same-ear recurrence rate was 28%; 76% of recurrences involved the same ear(s) as initial presentation. Recurrences that occurred after longer disease-free intervals were more likely to involve the opposite ear than early recurrences (p = 0.02). Female sex (40.4% versus 32.7%, p = 0.01) and history of previous BPPV (57.5% versus 32.4%, p < 0.0005) were associated with increased risk of recurrence, while history of Menière's disease, diabetes mellitus, and traumatic etiology were not. Approximately, half (56%) of recurrences occurred within 1 year of resolution. Conclusions: A large single-institution study of recurrence in BPPV is presented along with Kaplan–Meier disease-free survival curves. Female sex and history of previous BPPV were associated with increased recurrence, while previously suspected risk factors for recurrence including history of Menière's disease, diabetes, and trauma were not. Remote recurrence is more likely to involve the contralateral ear than early recurrence. These data solidify the expected course of treated BPPV allowing for improved clinical care and patient counseling.

7 May 2018 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Open access
ALAlexander L. Luryi
Alexander L. Luryi
JLJuliana Lawrence
Juliana Lawrence
MLMichael LaRouere
Michael LaRouere
SBSeilesh Babu
Seilesh Babu
DBDennis I. Bojrab
Dennis I. Bojrab
CSChristopher A. Schutt
Christopher A. Schutt
Objective: To report treatment of benign paroxysmal positional vertigo (BPPV) in patients unable to undergo traditional canalith repositioning maneuvers (CRMs) using a particle repositioning chair (PRC). Methods: A retrospective chart review was conducted at a single high-volume otology practice of patients diagnosed with BPPV from 2007 to 2017 with immobility prohibiting use of traditional CRMs. Patients were diagnosed and treated using a PRC, and outcome measures including resolution, recurrence, and number of treatment visits were recorded. Results: A total of 34 patients meeting criteria were identified, 24 of whom had cervical spine disease and 10 of whom had other prohibitive immobility. Symptoms were present for between 5 days and 11 years at presentation, with mean and median of 552 and 90 days, respectively. Symptoms resolved in 68% of patients and recurred in 13% of those patients. Most patients required 1 treatment visit. Conclusions: Successful treatment of patients with BPPV and concomitant immobility prohibiting traditional CRMs is reported using the PRC. Benign paroxysmal positional vertigo in the setting of immobility is an indication for treatment with a PRC if available.

1 May 2018 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
ALAlexander L. Luryi
Alexander L. Luryi
DWDavid Wright
David Wright
JLJuliana Lawrence
Juliana Lawrence
SBSeilesh Babu
Seilesh Babu
MLMichael LaRouere
Michael LaRouere
CSChristopher A. Schutt
Christopher A. Schutt

19 July 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TOTaylor D. Ottesen
Taylor D. Ottesen
Jeffrey A. WickershamJeffrey A. Wickersham
Jeffrey A. Wickersham
JLJuliana C. Lawrence
Juliana C. Lawrence
SASergii Antoniak
Sergii Antoniak
OZOleksandr Zezuilin
Oleksandr Zezuilin
FAFredrick L. Altice
Fredrick L. Altice
Background: HIV incidence and mortality are increasing in Ukraine despite their reductions globally, in part due to suboptimal antiretroviral therapy (ART) coverage in key populations of people with HIV (PWH) where the epidemic is concentrated. As physicians are gatekeepers to ART prescription, stigma and discrimination barriers are understudied as a key to meeting HIV treatment targets in key populations. Methods: A national sample (N = 204) of ART-prescribing physicians in Ukraine were surveyed between August and November 2019. Participants underwent a series of randomized, hypothetical HIV clinical scenarios and decided whether to initiate or defer (or withhold) ART. Scenarios varied based on 5 distinct CD4 counts (CD4: 17, 176, 305, 470, or 520 cells/mL) and 10 different PWH key populations. Z scores and McNemar’s test for paired samples were used to assess differences between key populations and CD4 count. Feeling thermometers were used to assess stigma-related measures toward key populations among physicians. Results: Physicians were highly experienced (mean = 19 years) HIV treaters, female (80.4%), and trained in infectious diseases (76.5%). Patients who drink alcohol (range: 21.6%-23.5%) or use (PWUD range: 16.7%-20.1%) or inject (PWID range: 15.5%-20.1%) drugs were most likely to have ART deferred, even at AIDS-defining CD4 counts. PWID maintained on methadone, however, were significantly (p<0.001) less likely to have ART deferred compared with those who were not (range: 7.8%-12.7%) on methadone. Men who have sex with men (range: 5.4%-10.8%), transgender women (range: 4.9%-11.3%), sex workers (range: 3.9%-10.3%),and having an HIV-uninfected sex partner (range: 3.9%-9.3%) had the lowest likelihood of ART deferral. Increasing levels of stigma (i.e., feeling thermometers) towards a key population was correlated with ART deferral (i.e., discrimination). Conclusions: Despite international and Ukrainian guidelines recommending ART prescription for all PWH, irrespective of risk or CD4 count, ART deferral by experienced HIV experts remains high in certain key populations, especially in PWH and substance use disorders. Strategies that initiate ART immediately after diagnosis (i.e., rapid start antiretroviral therapy), independent of risk group, should be prioritized to truly mitigate the current epidemic.

1 January 2018 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
ALAlexander Leo Luryi
Alexander Leo Luryi
JLJuliana Lawrence
Juliana Lawrence
DBDennis Bojrab
Dennis Bojrab
MLMichael LaRouere
Michael LaRouere
SBSeilesh Babu
Seilesh Babu
CSChristopher A. Schutt
Christopher A. Schutt
Background: Meniere's disease (MD)-associated benign paroxysmal positional vertigo (BPPV) is complex and difficult to diagnose, and reports of its prevalence, pathologic features and outcomes are sparse and conflicting. Objective: Report disease characteristics and outcomes associated with the presence of MD in patients with BPPV. Materials/methods: A retrospective study of patients with BPPV between 2007 and 2017 at a single, high-volume institution. Results: Of 1581 patients with BPPV identified, 7.1% had MD and 71.9% of those patients had BPPV in the same ear(s) as MD. Patients with MD were more likely to have lateral semicircular canalithiasis (11.6% vs. 5.5%, p =.009) and multiple canalithiasis (7.1% vs. 2.5%, p=.005). MD was associated with an increased rate of resolution of BPPV (p =.008) but also increased time to resolution (p =.007). There was no association between MD and recurrence of BPPV. Conclusions: MD is associated with lateral canalithiasis. Contrary to prior reports, BPPV in MD can affect either ear and was not associated with poorer outcomes than idiopathic BPPV. Significance: The largest series to date investigating disease and outcome characteristics for BPPV in MD is presented. These data inform diagnosis and expectations in the management of these complex patients.

1 October 2020 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
JSJason L. Schwartz
Jason L. Schwartz
JLJuliana C. Lawrence
Juliana C. Lawrence